Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT00172666]
Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT00172666]
Bio2RDF identifier
NCT00172666
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00172666
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Although SLE and RA are ...... mmune
control subjects.
brief title [clinicaltrials_vocabulary:brief-title]
Decoy Receptor 3 (DcR3) Polymo ...... emic Lupus Erythematosus (SLE)
completion date [clinicaltrials_vocabulary:completion-date]
2006-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Abnormal immune respons ...... diseases RA and SLE.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-09-12T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
keyword [clinicaltrials_vocabulary:keyword]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2006-03-29T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00172666
official title [clinicaltrials_vocabulary:official-title]
Investigating Genetic Polymorp ...... d Systemic Lupus Erythematosus
org study id [clinicaltrials_vocabulary:org-study-id]
9.361.701.218
overall contact [clinicaltrials_vocabulary:overall-contact]
overall contact backup [clinicaltrials_vocabulary:overall-contact-backup]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
secondary id [clinicaltrials_vocabulary:secondary-id]
NSC 94-2320-B-002-085
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2005-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2004-12-01T00:00:00Z
identifier
clinicaltrials:NCT00172666
title
Decoy Receptor 3 (DcR3) Polymo ...... emic Lupus Erythematosus (SLE)
@en
type
label
Decoy Receptor 3 (DcR3) Polymo ...... ) [clinicaltrials:NCT00172666]
@en